| Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012 | 2086 | 2012 |
| Ocrelizumab versus placebo in primary progressive multiple sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... New england journal of medicine 376 (3), 209-220, 2017 | 1996 | 2017 |
| Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... New England Journal of Medicine 376 (3), 221-234, 2017 | 1927 | 2017 |
| Postnatal NG2 proteoglycan–expressing progenitor cells are intrinsically multipotent and generate functional neurons S Belachew, R Chittajallu, AA Aguirre, X Yuan, M Kirby, S Anderson, ... The Journal of cell biology 161 (1), 169-186, 2003 | 587 | 2003 |
| Elongator controls the migration and differentiation of cortical neurons through acetylation of α-tubulin C Creppe, L Malinouskaya, ML Volvert, M Gillard, P Close, O Malaise, ... Cell 136 (3), 551-564, 2009 | 570 | 2009 |
| Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy T Plavina, M Subramanyam, G Bloomgren, S Richman, A Pace, S Lee, ... Annals of neurology 76 (6), 802-812, 2014 | 473 | 2014 |
| Neurotransmitters as early signals for central nervous system development L Nguyen, JM Rigo, V Rocher, S Belachew, B Malgrange, B Rogister, ... Cell and tissue research 305, 187-202, 2001 | 459 | 2001 |
| Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled … L Kappos, JS Wolinsky, G Giovannoni, DL Arnold, Q Wang, C Bernasconi, ... JAMA neurology 77 (9), 1132-1140, 2020 | 416 | 2020 |
| The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐and glycine‐gated currents JM Rigo, G Hans, L Nguyen, V Rocher, S Belachew, B Malgrange, ... British journal of pharmacology 136 (5), 659-672, 2002 | 413 | 2002 |
| NG2-expressing cells in the subventricular zone are type C–like cells and contribute to interneuron generation in the postnatal hippocampus AA Aguirre, R Chittajallu, S Belachew, V Gallo The Journal of cell biology 165 (4), 575-589, 2004 | 310 | 2004 |
| Proliferative generation of mammalian auditory hair cells in culture B Malgrange, S Belachew, M Thiry, L Nguyen, B Rogister, ML Alvarez, ... Mechanisms of development 112 (1-2), 79-88, 2002 | 220 | 2002 |
| Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions C Elliott, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, C Bernasconi, ... Multiple Sclerosis Journal 25 (14), 1915-1925, 2019 | 201 | 2019 |
| Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis C Elliott, S Belachew, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, ... Brain 142 (9), 2787-2799, 2019 | 193 | 2019 |
| Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results H Butzkueven, L Kappos, F Pellegrini, M Trojano, H Wiendl, RN Patel, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1190-1197, 2014 | 188 | 2014 |
| Autocrine/paracrine activation of the GABAA receptor inhibits the proliferation of neurogenic polysialylated neural cell adhesion molecule-positive (PSA-NCAM+) precursor cells … L Nguyen, B Malgrange, I Breuskin, L Bettendorff, G Moonen, S Belachew, ... Journal of Neuroscience 23 (8), 3278-3294, 2003 | 186 | 2003 |
| Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies X Yuan, R Chittajallu, S Belachew, S Anderson, CJ McBain, V Gallo Journal of neuroscience research 70 (4), 529-545, 2002 | 176 | 2002 |
| Cell “circadian” cycle: new role for mammalian core clock genes L Borgs, P Beukelaers, R Vandenbosch, S Belachew, L Nguyen, ... Cell Cycle 8 (6), 832-837, 2009 | 173 | 2009 |
| Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease R Brouns, V Thijs, F Eyskens, M Van den Broeck, S Belachew, ... Stroke 41 (5), 863-868, 2010 | 163 | 2010 |
| Identification of Sox17 as a transcription factor that regulates oligodendrocyte development J Sohn, JA Natale, LJ Chew, S Belachew, Y Cheng, A Aguirre, J Lytle, ... Journal of Neuroscience 26 (38), 9722-9735, 2006 | 160 | 2006 |
| Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension SL Hauser, L Kappos, DL Arnold, A Bar-Or, B Brochet, RT Naismith, ... Neurology 95 (13), e1854-e1867, 2020 | 134 | 2020 |
